Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 241 AL 255

Comorbidity and Management of Concurrent Psychiatric and Medical Disorders

Bayer TA, Van Patten R, Hershkowitz D, Epstein-Lubow G, Rudolph JL.

Psychiatr Clin North Am. 2022 Dec;45(4):745-763. doi: 10.1016/j.psc.2022.07.006. Epub 2022 Oct 14.

Ecological Effects of VR-Based Cognitive Training on ADL and IADL in MCI and AD patients: A Systematic Review and Meta-Analysis

Son C, Park JH.

Int J Environ Res Public Health. 2022 Nov 29;19(23):15875. doi: 10.3390/ijerph192315875.

Deep learning-based speech analysis for Alzheimer's disease detection: a literature review

Yang Q, Li X, Ding X, Xu F, Ling Z.

Alzheimers Res Ther. 2022 Dec 14;14(1):186. doi: 10.1186/s13195-022-01131-3.

Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes

Jung SH, Kim HR, Chun MY, Jang H, Cho M, Kim B, Kim S, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Jang JW, Kim Y, Hong JY, Choi SH, Noh Y, Kim KW, Kim SE, Lee JS, Jung NY, Lee J, Lee AY, Kim BC, Cho SH, Cho H, Kim JH, Jung YH, Lee DY, Lee JH, Lee ES, Kim SJ, Moon SY, Son SJ, Hong CH, Bae JS, Lee S, Na DL, Seo SW, Cruchaga C, Kim HJ, Won HH.

JAMA Netw Open. 2022 Dec 1;5(12):e2247162. doi: 10.1001/jamanetworkopen.2022.47162.

Development of a Gastrointestinal-Myoelectrical-Activity-Based Nomogram Model for Predicting the Risk of Mild Cognitive Impairment

Li B, Ji S, Peng A, Yang N, Zhao X, Feng P, Zhang Y, Chen L.

Biomolecules. 2022 Dec 12;12(12):1861. doi: 10.3390/biom12121861.

An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer's Disease

Verma RK, Pandey M, Chawla P, Choudhury H, Mayuren J, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW, Obaidur Rahman S.

CNS Neurol Disord Drug Targets. 2022;21(10):901-912. doi: 10.2174/1871527320666210512014505.

A Concise Overview of Biosensing Technologies for the Detection of Alzheimer's Disease Biomarkers

Talebi M, Esmaeeli H, Talebi M, Farkhondeh T, Samarghandian S.

Curr Pharm Biotechnol. 2022;23(5):634-644. doi: 10.2174/2666796702666210709122407.

Lipids as Early and Minimally Invasive Biomarkers for Alzheimer's Disease

Casas-Fernández E, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2022;20(8):1613-1631. doi: 10.2174/1570159X19666211102150955.

Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease

Kumari S, Singh A, Singh AK, Yadav Y, Bajpai S, Kumar P, Upadhyay AD, Shekhar S, Dwivedi S, Dey AB, Dey S.

J Alzheimers Dis. 2022;85(1):249-260. doi: 10.3233/JAD-215347.

A Case of Possible Chronic Traumatic Encephalopathy and Alzheimer's Disease in an Ex-Football Player

Fesharaki-Zadeh A.

Neurologist. 2022 Sep 1;27(5):249-252. doi: 10.1097/NRL.0000000000000391.

Sphingomyelins and ceramides: possible biomarkers for dementia?

Loft LMI, Moseholm KF, Pedersen KKW, Jensen MK, Koch M, Cronjé HT.

Curr Opin Lipidol. 2022 Feb 1;33(1):57-67. doi: 10.1097/MOL.0000000000000804.

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease

Creese B, Ismail Z.

Alzheimers Res Ther. 2022 Jan 5;14(1):2. doi: 10.1186/s13195-021-00949-7.

Exosomes-Potential for Blood-Based Marker in Alzheimer's Disease

Li CC, Hsu WF, Wo AM.

Acta Neurol Taiwan. 2022 Jan 25;31(1):1-6.

Imaging biomarkers for Alzheimer's disease and glaucoma: Current and future practices

Martucci A, Picchi E, Di Giuliano F, Pocobelli G, Mancino R, Toschi N, Russo R, Floris R, Garaci F, Nucci C.

Curr Opin Pharmacol. 2022 Feb;62:137-144. doi: 10.1016/j.coph.2021.12.003. Epub 2022 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias